Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Tulusan

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb studyG von Minckwitz, S D Costa, G Raab, et al.
Nuklearmedizin. Nuclear Medicine|February 24, 2004
[Sentinel node biopsy in breast cancer]T Kühn, A Bembenek, H Büchels, et al.
Der Pathologe|June 11, 2004
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]T Kühn, A Bembenek, H Büchels, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb studyG von Minckwitz, S D Costa, G Raab, et al.
Nuklearmedizin. Nuclear Medicine|February 24, 2004
[Sentinel node biopsy in breast cancer]T Kühn, A Bembenek, H Büchels, et al.
Der Pathologe|June 11, 2004
[Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing]T Kühn, A Bembenek, H Büchels, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Pageof 7